1. 乐发500





        1. Pharmaceuticals / services
          About

          About Us

          Dedicated to be an exquisite specialized pharmaceutical research company

          Beijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and authorized production for chemical innovative drugs and high-end generic drugs.Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liquid chromatograph, gas chromatograph, ion chromatography...

          MORE
          NEWS

          News

          • Company News
          • |
          • Industry News
          2024-05-08

          Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved

          Our new formulation L-Ornithine-L-Aspartate Infusion for injection( 5gm/10ml ) has been approved by China SFDA on 23th April 2020. The injection registration certificate...

          2024-05-08

          Nafcillin Sodium for injection has been approved by China SF

          Our new formulation Nafcillin Sodium for injection (1.0gram per ampoule) has been approved by China SFDA on 4th May 2015. The API registration certificate no. is H2015308...

          2024-05-08

          Olopatadine hydrochloride tablets has been approved by China SF

          Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and ...

          More
          2024-05-08

          NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs

          NMPA Announcement on Issues Pertaining to Online Application for Drug Registration Affairs As per the requirements of the Notice of the General Office of the State Counci...

          2024-05-08

          Center for Drug evalsuation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and

          Center for Drug evalsuation of NMPA Announced on Issuing the Administrative easures for Communication of Drug R&D and Technical Review Pursuant to the Announcement of NMPA...

          More




            1. XML地图